Viroinformatics-Based Analysis of SARS-CoV-2 Core Proteins for Potential Therapeutic Targets

SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a novel coronavirus for which no known effective antiviral drugs are available. In the present study, to accelerate the discovery of potential drug candidates, bioinformatics-based in silico drug discovery approaches are utilized. We pe...

Full description

Bibliographic Details
Main Authors: Lokesh Agrawal, Thanasis Poullikkas, Scott Eisenhower, Carlo Monsanto, Ranjith Kumar Bakku, Min-Hua Chen, Rajkumar Singh Kalra
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Antibodies
Subjects:
Online Access:https://www.mdpi.com/2073-4468/10/1/3